-
-
-
Akeso's 2024 First Half Interim Results: Expanding Global Lead in IO Bispecific Antibodies, Advancing New Therapies, and Accelerating Commercialization
Approval of ivonescimab for 2L+ EGFRm NSCL; HARMONi-A is the only phase III study that demonstrates significant benefit across all subgroups for PFS,and is also the only study to achieve the primary e
Akeso, Inc. / 08-29
-
-
-
-
UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines
SHENZHEN,China,Aug. 28,2024-- UTime Limited (NASDAQ:WTO) ("UTime" or the "Company")has officially announced the signing of a non-disclosure agreement (the "NDA") with Bow
UTime Limited / 08-29
-
-
-
-
Babilou Family Singapore Empowers Educators with Global Best Practices Through Inter-Country Learning Journey Initiative
The initiative provides opportunities forBabilou Family Singapore\'s early childhood educators to share best practices,equipping them with global insights.
Babilou Family Singapore / 08-29
-
-
-
-
Doo Prime Celebrated Partnership Success at Old Trafford
LIMASSOL,Cyprus,Aug. 29,2024--Doo Prime successfully concluded a premier partner event held at the renowned Old Trafford Stadium on Saturday,August 10,2024. As one of the most significant gatherings
Doo Prime / 08-29
-
-
-
-
Selling fast! This £7 Boots serum promises to hydrate, clear blemishes and smooth fine lines and wrinkles
SHOPPING: Beauty buffs looking to refresh their skincare routine are turning to this new skincare range from Boots - with each product coming in at £8 or under
-
-
-
-
AAC Technologies's CFO Guo Dan: Expects 15% Growth in Revenue of Main Business while the Growth of the Group May Exceeds 30% After PSS Consolidation
HONG KONG,Aug. 27,2024-- On August 22,AAC Technologies (02018.HK) held its 2024 interim results presentation in Hong Kong,delivering remarkably impressive performance.
AAC Technologies / 08-28
-
-
-
-
Stamus Networks Recognized as a Sample Vendor for NDR (Network Detection and Response) in Four Recently Published Gartner® Hype Cycle™, 2024 Reports
INDIANAPOLIS and PARIS,Aug. 27,2024-- Stamus Networks,a global provider of high-performance network-based threat detection and response (NDR) systems,today announced it has been named a Sample Vendor
Stamus Networks / 08-28
-
-
-
-
BAIYU Enters into Definitive Agreement to Acquire Leading Energy Storage and Lithium Battery Company, Expanding into Renewable Energy Market
BRADENTON,Fla.,Aug. 27,2024-- BAIYU Holdings,Inc. ("BAIYU" or the "Company") (Nasdaq: BYU),a leading B2B bulk commodity e-commerce platform and supply chain service provider,today
BAIYU Holdings, Inc. / 08-28
-
-
-
-
GenScript Subsidiary Legend Biotech Achieves Breakthrough with Cilta-cel Approval in China, Offering New Hope for Multiple Myeloma Patients
PISCATAWAY,N.J.,Aug. 27,2024-- Legend Biotech (NASDAQ: LEGN),a subsidiary of GenScript Biotech Corporation (hereinafter referred to as "GenScript"),a global leader in life sciences research
GenScript Biotech Corporation / 08-28
-
-
-
-
Jenscare, with innovative TTVR, releases 2024H1 interim results
BEIJING,Aug. 28,2024-- Jenscare Scientific Co.,Ltd. ("Jenscare" or the "Company") (HKEX: 9877),an innovative medical device company dedicated to interventional treatment for struct
Jenscare Scientific Co., Ltd. / 08-28
-